Schrödinger Q1 revenue rises 63% to $59.6 million; net loss widens, guidance held
Schrödinger reported first-quarter 2025 total revenue of $59.6 million, up 63% from $36.6 million a year earlier, led by software revenue of $48.8 million. The net loss widened to $59.8 million from $54.7 million, and the loss per share was $0.82 compared with $0.76. The company maintained its previously issued 2025 financial guidance.
Key points
- Total revenue rose 63% to $59.6 million; software revenue rose 46% to $48.8 million, partly due to early renewals by large customers.
- Net loss was $59.8 million versus $54.7 million a year earlier; loss per share was $0.82 versus $0.76.
- Non-GAAP net loss was $46.7 million versus $62.4 million in the first quarter of 2024.
- Full-year 2025 guidance was maintained, including software revenue growth of 10% to 15% and drug discovery revenue of $45 million to $50 million.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.